Gregory Morrison

ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support.

Part of Woodbridge Co. Ltd. /New/, Thomson Legal & Regulatory Ltd. provides information and publishing services to various markets including legal and regulatory, financial services, scientific, reference, healthcare, education, and corporate training. The company is based in Brisbane, Australia and offers its services through web-based information delivery platforms.

Tornier NV is a global medical device company, which is focused on serving extremities specialists that treat orthopedic conditions of the shoulder, elbow, wrist, hand, ankle and foot. The company offers orthopedic reconstructive products in four major categories: Upper Extremity Joints and Trauma, Lower Extremity Joints and Trauma, Sports Medicine and Orthobiologics, and Large Joints and Other. It operates through orthopedic products segment, which includes the design, manufacture and marketing of joint implants and other related products. Tornier was founded in 2006 and is headquartered in Amsterdam, the Netherlands.

Wright Medical Group NV engages in the provision of medical device products. It operates through the following segments: U.S. Lower Extremities and Biologics; U.S. Upper Extremities; International Extremities and Biologics; and Corporate. The U.S. Lower Extremities and Biologics includes the sale of its lower extremities products, such as joint implants and bone fixation devices for the foot and ankle; and biologics products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The U.S. Upper Extremities segment focuses on joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; and products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries, and other ancillary products. The International Extremities and Biologics segment covers all lower and upper extremities products, as well as associated biologics products. The Corporate segment reflects general and administrative expenses not specifically associated with other segments. The company was founded by Frank O. Wright in 1950 and is headquartered in Amsterdam, the Netherlands.

Part of Boston Scientific Corp., Schneider (Europe) GmbH is a Swiss company that makes stents used to prop open arteries and other devices for angioplasty. The company is based in Bulach, Switzerland. Schneider (Europe was acquired by Boston Scientific Corp. from Pfizer Inc. on September 10, 1998 for $2,100 million.